These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21529377)

  • 1. [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.
    Würschmidt F; Petersen C; Wahl A; Dahle J; Kretschmer M
    Radiat Oncol; 2011 May; 6():44. PubMed ID: 21529377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
    Wahart A; Guy JB; Vallard A; Geissler B; Ben Mrad M; Falk AT; Prevot N; de Laroche G; Rancoule C; Chargari C; Magné N
    Br J Radiol; 2016; 89(1058):20150579. PubMed ID: 26648528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.
    Pinkawa M; Holy R; Piroth MD; Klotz J; Nussen S; Krohn T; Mottaghy FM; Weibrecht M; Eble MJ
    Strahlenther Onkol; 2010 Nov; 186(11):600-6. PubMed ID: 20936457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
    Schwarzenböck SM; Kurth J; Gocke Ch; Kuhnt T; Hildebrandt G; Krause BJ
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40 Suppl 1():S28-35. PubMed ID: 23576101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.
    Lépinoy A; Cochet A; Cueff A; Cormier L; Martin E; Maingon P; Bosset JF; Brunotte F; Créhange G
    Radiother Oncol; 2014 Apr; 111(1):120-5. PubMed ID: 24780635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients.
    Picchio M; Berardi G; Fodor A; Busnardo E; Crivellaro C; Giovacchini G; Fiorino C; Kirienko M; Incerti E; Messa C; Gianolli L; Di Muzio N
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1270-9. PubMed ID: 24599378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of androgen deprivation therapy on intraprostatic tumour volume identified on
    Chan J; Carver A; Brunt JN; Vinjamuri S; Syndikus I
    Br J Radiol; 2017 Mar; 90(1071):20160818. PubMed ID: 27993093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
    Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
    Fodor A; Berardi G; Fiorino C; Picchio M; Busnardo E; Kirienko M; Incerti E; Dell'Oca I; Cozzarini C; Mangili P; Pasetti M; Calandrino R; Gianolli L; Di Muzio NG
    BJU Int; 2017 Mar; 119(3):406-413. PubMed ID: 27104782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.
    Tilki D; Reich O; Graser A; Hacker M; Silchinger J; Becker AJ; Khoder W; Bartenstein P; Stief CG; Loidl W; Seitz M
    Eur Urol; 2013 May; 63(5):792-6. PubMed ID: 22902037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.
    Chang JH; Lim Joon D; Lee ST; Gong SJ; Anderson NJ; Scott AM; Davis ID; Clouston D; Bolton D; Hamilton CS; Khoo V
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e691-6. PubMed ID: 22658218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients.
    Casamassima F; Masi L; Menichelli C; Bonucci I; Casamassima E; Lazzeri M; Gulisano M; Aterini S
    Tumori; 2011; 97(1):49-55. PubMed ID: 21528664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.
    Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C
    BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
    Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K
    Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
    Perez-Romasanta LA; Bellon-Guardia M; Torres-Donaire J; Lozano-Martin E; Sanz-Martin M; Velasco-Jimenez J
    Clin Transl Oncol; 2013 Apr; 15(4):283-93. PubMed ID: 22865325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
    Rischke HC; Eiberger AK; Volegova-Neher N; Henne K; Krauss T; Grosu AL; Jilg CA
    Adv Med Sci; 2016 Sep; 61(2):212-218. PubMed ID: 26895459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.
    Vees H; Steiner C; Dipasquale G; Chouiter A; Zilli T; Velazquez M; Namy S; Ratib O; Buchegger F; Miralbell R
    Radiat Oncol; 2012 Aug; 7():134. PubMed ID: 22873771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.